United States · Bill · HR
H.R. 938 (116th)
BLOCKING Act of 2019
Introduced
31 January 2019
Last action
2 May 2019 · Reported
Status
Placed on the Union Calendar, Calendar No. 24.
Sponsors
Rep. Schrader, Kurt [D-OR-5], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Craig, Angie [D-MN-2], Rep. Dingell, Debbie [D-MI-6], Rep. Ruiz, Raul [D-CA-25], Rep. Pallone, Frank [D-NJ-6], Rep. Eshoo, Anna G. [D-CA-18], Rep. Kennedy, Joseph P., III [D-MA-4], Rep. Matsui, Doris O. [D-CA-7], Rep. Rush, Bobby L. [D-IL-1], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Clarke, Yvette D. [D-NY-9], Rep. Walden, Greg [R-OR-2], Rep. Schakowsky, Janice D. [D-IL-9], Rep. McAdams, Ben [D-UT-4], Rep. Mucarsel-Powell, Debbie [D-FL-26], Rep. Meadows, Mark [R-NC-11]
Subjects
Healthcare
Source updated
7 April 2025
Summary
Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 This bill modifies provisions related to market exclusivity for a generic drug. Currently, the Food and Drug Administration (FDA) awards 180 days of exclusivity on the market to a first applicant to file a qualifying application for market approval of a generic drug. Generally, this exclusivity period begins upon a first applicant's commercial marketing of the drug. The bill authorizes the FDA to approve a subsequent generic drug application prior to a first applicant's first date of commercial marketing if (1) the subsequent application is ready for full approval, (2) a first applicant's application has been pending for at least 30 months, and (3) the approval of a first applicant's application is not precluded by patent infringement claims asserted against that first applicant.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
31 January 2019
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
31 January 2019
Introduced
Introduced in House
Source: IntroReferral
31 January 2019
Introduced
Introduced in House
Source: IntroReferral
2 February 2019
Referred
Referred to the Subcommittee on Health.
Source: Committee
27 March 2019
Committee
Forwarded by Subcommittee to Full Committee by Voice Vote .
Source: Committee
27 March 2019
Committee
Subcommittee Consideration and Mark-up Session Held.
Source: Committee
3 April 2019
Reported
Ordered to be Reported by Voice Vote.
Source: Committee
3 April 2019
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
2 May 2019
Calendars
Placed on the Union Calendar, Calendar No. 24.
Source: Calendars
2 May 2019
Reported
Reported by the Committee on Energy and Commerce. H. Rept. 116-46.
Source: Committee
2 May 2019
Reported
Reported by the Committee on Energy and Commerce. H. Rept. 116-46.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Reported in House · 2 May 2019 · Download file
- Introduced in House · 31 January 2019 · Download file
Documents
6 official files
Reported in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported in House (text)
Reported in House · EN · 2 May 2019
Reported in House (PDF)
Reported in House · EN · 2 May 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported to House
summary · EN · 2 May 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 31 January 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (PDF)
Introduced in House · EN · 31 January 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 31 January 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Schrader, Kurt [D-OR-5] · D · Sponsor
- Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Sponsor
- Rep. Craig, Angie [D-MN-2] · D · Cosponsor
- Rep. Dingell, Debbie [D-MI-6] · D · Cosponsor
- Rep. Ruiz, Raul [D-CA-25] · D · Cosponsor
- Rep. Pallone, Frank [D-NJ-6] · D · Cosponsor
- Rep. Eshoo, Anna G. [D-CA-18] · D · Cosponsor
- Rep. Kennedy, Joseph P., III [D-MA-4] · D · Cosponsor
- Rep. Matsui, Doris O. [D-CA-7] · D · Cosponsor
- Rep. Rush, Bobby L. [D-IL-1] · D · Cosponsor
- Rep. Van Drew, Jefferson [R-NJ-2] · D · Cosponsor
- Rep. Clarke, Yvette D. [D-NY-9] · D · Cosponsor
- Rep. Walden, Greg [R-OR-2] · R · Cosponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Cosponsor
- Rep. McAdams, Ben [D-UT-4] · D · Cosponsor
- Rep. Mucarsel-Powell, Debbie [D-FL-26] · D · Cosponsor
- Rep. Meadows, Mark [R-NC-11] · R · Cosponsor
- · hsif00 · Standing
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/938
- Open data entity: https://api.congress.gov/v3/bill/116/hr/938
- us · 116-hr-938 · source updated 7 April 2025